1/24/2020  5:29:59 PM Chg. -8.00 Volume Bid5:30:00 PM Ask5:30:00 PM Market Capitalization Dividend Y. P/E Ratio
2,356.00GBX -0.34% 16,849
Turnover(GBP): 401,131.4000
2,356.00Bid Size: 110 2,366.00Ask Size: 49 2.04 bill.GBP - -

Business description

Victrex plc is one of the world’s leading manufacturers of high performance polyaryletherketone materials. Victrex plc comprises two divisions: Victrex Polymer Solutions that focuses on transport, industrial and the electronics markets and Invibio Biomaterial Solutions that focuses on providing specialist solutions for medical device manufacturers. Victrex Polymer Solutions specializes in the development and manufacture of high performance polyaryletherketones such as VICTREX® PEEK polymer, VICOTE® coatings, APTIV® films, and VICTREX Pipes™. Invibio® Biomaterial Solutions provides access to highly specialized biocompatible PEEK-based materials and services for the surgical and medical device markets. With more than 30 years of experience, Victrex manufacturing facilities are based in the UK and they have technology, customer service and distribution teams that spans more than 40 countries worldwide and is headquartered in Lancashire, UK.

Management board & Supervisory board

Jakob Sigurdsson
Management board
Richard Armitage, Martin Court
Supervisory board
Lawrence Pentz, Brendan Connolly, David Thomas, Jakob Sigurdsson, Jane Toogood, Janet Ashdown, Martin Court, Pamela Kirby, Richard Armitage

Company data

Name: Victrex plc
Address: Victrex Technology Centre, Hillhouse International, Thornton Cleveleys,UK-Lancashire FY5 4QD
Phone: +44-1253-897700
Fax: +44-1253-897701
E-mail: -
Internet: www.victrexplc.com/
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 9/30
Free Float: 56.32%
IPO date: -

Investor relations

Name: Andrew Hanson
IR phone: +44-1253-898121
IR Fax: -
IR e-mail: ir@victrex.com

Company calendar

CW 5 | 1/30/2020 Ex-Dividend
CW 6 | 2/6/2020 General Shareholder Meeting
CW 8 | 2/21/2020 Dividend Payment
CW 20 | 5/11/2020 Interim Report 2nd Quarter/6 Months

Main Shareholders

M&G Invesment Management Ltd
T. Rowe Price Associates, Inc.
BlackRock Inc
Schroders plc
Mondrian Investment Partners Ltd
Ameriprise Financial Inc.
Baillie Gifford
Standard Life Aberdeen